Key result
A review of current NICE and ESC guidelines for heart failure and cardiac device therapy highlights differences that may impact clinical practice.
Why the study?
Advances in heart failure medication and cardiac device therapy have been incorporated into guidelines with varying success, warranting evaluation of guideline differences and their clinical impact.
This review highlights differences between NICE and ESC guidelines for heart failure and cardiac device therapy and evaluates their potential impact on clinical practice.
Guideline comparisons may aid local HF care optimization; leaves open questions on best implementation strategies.
Guidelines help clinicians to deliver high-quality care with therapies based on up-to-date evidence. There has been significant progress in the management of heart failure with regards to both medication and cardiac device therapy. These advances have been incorporated into national and international guidelines with varying degrees of success. This article reviews current guidance from the National Institute of Health and Care Excellence in the UK and compares this with European Society of Cardiology guidelines, and evaluates how differences between them may impact on clinical practice.
No takes yet. Share an insight, caveat, or question.
Naraen et al. (2023) conducted a review in Heart failure. NICE and ESC guidelines was evaluated. A review of current NICE and ESC guidelines for heart failure and cardiac device therapy highlights differences that may impact clinical practice.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: